TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 22 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,314 | -38.8% | 13,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,783 | -84.6% | 13,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $24,570 | +26.8% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $19,370 | -12.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | -15.4% | 13,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $26,000 | -23.5% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -5.6% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $36,000 | -28.0% | 13,000 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $50,000 | -40.5% | 13,000 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $84,000 | -21.5% | 13,000 | 0.0% | 0.01% | -36.4% |
| Q1 2021 | $107,000 | -29.6% | 13,000 | 0.0% | 0.01% | -38.9% |
| Q4 2020 | $152,000 | +145.2% | 13,000 | +8.3% | 0.02% | +100.0% |
| Q3 2020 | $62,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,125,322 | $8,251,000 | 3.72% |
| Ikarian Capital, LLC | 2,788,853 | $5,577,000 | 1.02% |
| Telemetry Investments, L.L.C. | 100,000 | $200,000 | 0.24% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $57,000 | 0.08% |
| JOHNSON & JOHNSON | 84,003 | $168,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $693,000 | 0.04% |
| X-Square Capital, LLC | 17,973 | $36,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $537,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $910,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $95,000 | 0.00% |